Stem-cell therapies represent a promising field of research with great potential for medicine. With the aim of overviewing the best practices in this area and discussing the hurdles that need to be overcome to implement it on regenerative medicine, CARDIOPATCH Project partner HSCSP (Hospital de la Santa Creu i Sant Pau) will organize a virtual event on the 23th of June.
The meeting will be held at 10:00 CET and is open to the scientific community active in regenerative medicine, hospitals, research centers, laboratories and other health actors mainly focused on cardiopathies.
To attend the event it is necessary to access this link on the day of the meeting at the scheduled time. The meeting ID is 957 0345 7456 and the passcode is 442924.
The event will start with the presentation about CAR-T cell therapy offered by Javier Briones, doctor with the Research Institute of the Hospital de la Santa Creu i Sant Pau (HSCSP).
After that, Gemma Arderiu, biomedical researcher of FIRHSCSP, will share her presentation regarding the obtention and miRNA regulation of ASCs to induce endothelial differentiation for therapeutic application.
Finally, researcher Nuria Montserrat, group leader at the Institute of Bioengineering of Catalonia (IBEC), one of the collaborating entities of the initiative, will explain the opportunities and clinical challenges of tissue engineering.
The event will be closed with a panel of discussion in order to address the comments and questions of the attendees, promote the exchange of knowledge and boost synergies and interactions.
The meeting is part of the program of actions designed by the CARDIOPATCH initiative to promote scientific dissemination and bring to the agents involved in the field of health and medicine the benefits of research.
Co-funded by the EU Interreg Sudoe Programme, via the European Regional Development Fund (ERDF), CARDIOPATCH project (Network of Excellence for the development of Advanced Therapies of Myocardial Infarction treatment based on regenerative medicine and 3D printing) is investigating new treatments for myocardial infarction to provide solutions to improve patients’ quality of life.
The initiative is focused on developing a stem-cell smart patch able to regenerate tissues damaged by infarction. The patch is currently in the first phase of a clinical trial on patients with chronic ischaemic cardiomyopathy. The project also aims to develop a roll-up 3D device which will allow the patch implantation in the heart through less invasive methods and a 3D system to generalize the patch’ production and streamline transport.
Coordinated by Clínica Universidad de Navarra (CUN), the project includes partners from Spain, France and Portugal. Alongside of CUN, the consortium is made up by CIMA Universidad de Navarra, via the Foundation for Applied Medical Research, Leartiker Technology Center, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, communication agency GUK, Centre Hospitalier Universitaire de Toulouse, the University of Montpellier (UM) - Institut des Biomolécules Max Mousseron (IBMM), GenIbet Biopharmaceuticals and the Instituto de Biologia Experimental e Tecnológica.
CARDIOPATCH Excellent Network born to advance in the field of Cardiac Regenerative Medicine and 3D printing applied to Myocardial Infarction treatment.
CARDIOPATCH project is co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF).
CARDIOPATCH project is co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF).
2021 © cardiopatch.eu. Legal notice / Privacy policy / Cookies policy